RP-A501

3 treatments and conditions followed through the public trial records. Not medical advice. How a status is set

Treatments and conditions

RP-A501
Treatment and conditionWhere it standsTrials
RP-A501 for cardiomyopathy, hypertrophicPhase 2 trial, as of 19 Nov 2026 (not yet checked by a person)2
RP-A501 for hypertrophy, left ventricularPhase 2 trial, as of 19 Nov 2026 (not yet checked by a person)1
RP-A501 for lysosomal storage diseasesPhase 2 trial, as of 19 Nov 2026 (not yet checked by a person)1